Literature DB >> 34150009

Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5.

Yumei Li1, Shengming Lin2, Xiaoliang Xie1, Haixia Zhu1, Tianyou Fan1, Song Wang2.   

Abstract

OBJECTIVE: This study aims to investigate the regulatory role of exosome lncRNA OIP5-AS1 in tumor progression and autophagy.
METHODS: Seventy-three cases of osteosarcoma (OS) tissues and 56 cases of adjacent normal tissues were collected to culture human OS cell line HOS. The exosomes secreted by OS cell line were isolated and collected. Apoptosis and exosome markers were detected by flow cytometry. A nude mouse model of OS was established. The gene expression levels of lncRNA OIP5-AS1, miR-153 and autophagy-related protein 5 (ATG5) were quantified by real-time quantitative PCR (RT-PCR). The binding sites of lncRNA OIP5-AS1 and miR-153 were predicted by Starbase3.0, and the binding sites of miR-153 and ATG5 were predicted by Targetscan7.2. The gene binding sites were verified by luciferase reporter gene detection or RNA immunoprecipitation (RIP). The relative level of protein was tested by Western blot. Transwell was applied to test migration and invasion of OS cells. The angiogenesis of OS cells was tested by tubule formation test.
RESULTS: The results of RT-PCR showed that lncRNA OIP5-AS1 levels were elevated in OS cells and exosomes secreted by cells. Cell function experiments revealed that the proliferation, migration, and invasion of OS cells were promoted by exosomal lncRNA OIP5-AS1. In exosomes, lncRNA OIP5-AS1 inhibited the expression of LC3-II and Beclin 1 proteins, indicating that exosomal lncRNA OIP5-AS1 inhibited autophagy. According to the results of bioinformatics tools and dual-luciferase reporter (DLR) assay or RNA immunoprecipitation (RIP), miR-153 targeted the 3'-UTR of lncRNA OIP5-AS1 and autophagy-related protein 5 (ATG5). The results of western blot (WB) assay showed that exosomal lncRNA OIP5-AS1 and down-regulated miR-153 led to the enhancement of ATG5 protein expression, while up-regulated miR-153 resulted in the decrease of ATG5 protein expression. ATG5 was negatively correlated with miR-153 and positively correlated with lncRNA OIP5-AS1. The results of tubule formation assay disclosed an increase in the angiogenesis level caused by the exosomal lncRNA OIP5-AS1, which was then reversed by the increase of miR-153 and decrease of ATG5.
CONCLUSION: Highly enriched exosomal lncRNA OIP5-AS1 can regulate OS tumor angiogenesis and autophagy through miR-153 and ATG5. AJTR
Copyright © 2021.

Entities:  

Keywords:  ATG5; Osteosarcoma; angiogenesis; autophagy; exosomal lncRNA OIP5; miR-153

Year:  2021        PMID: 34150009      PMCID: PMC8205742     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  29 in total

1.  Epidemiology and Risk Factors of Osteosarcoma.

Authors:  Leissan R Sadykova; Atara I Ntekim; Musalwa Muyangwa-Semenova; Catrin S Rutland; Jennie N Jeyapalan; Nataliya Blatt; Albert A Rizvanov
Journal:  Cancer Invest       Date:  2020-06-01       Impact factor: 2.176

2.  Endothelial-Specific Deficiency of ATG5 (Autophagy Protein 5) Attenuates Ischemia-Related Angiogenesis.

Authors:  David Sprott; David M Poitz; Irina Korovina; Athanasios Ziogas; Julia Phieler; Antonios Chatzigeorgiou; Ioannis Mitroulis; Andreas Deussen; Triantafyllos Chavakis; Anne Klotzsche-von Ameln
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06       Impact factor: 8.311

Review 3.  Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.

Authors:  Jin-Yan Wang; Yan Yang; Yajun Ma; Fen Wang; Aili Xue; Jing Zhu; Hui Yang; Qi Chen; Meili Chen; Lingling Ye; Hao Wu; Quan'an Zhang
Journal:  Biomed Pharmacother       Date:  2019-11-20       Impact factor: 6.529

4.  EWSAT1 Acts in Concert with Exosomes in Osteosarcoma Progression and Tumor-Induced Angiogenesis: The "Double Stacking Effect".

Authors:  Shi-Cong Tao; Ji-Yan Huang; Zhan-Ying Wei; Zi-Xiang Li; Shang-Chun Guo
Journal:  Adv Biosyst       Date:  2020-08-16

5.  LncRNA-XIST promotes the oxidative stress-induced migration, invasion and epithelial to mesenchymal transition of osteosarcoma cancer cells through miR-153-SNAI1 axis.

Authors:  Ji-Feng Wen; Yong-Qing Jiang; Chao Li; Xian-Kui Dai; Tong Wu; Wen-Zhe Yin
Journal:  Cell Biol Int       Date:  2020-06-09       Impact factor: 3.612

Review 6.  Autophagy in endothelial cells and tumor angiogenesis.

Authors:  Marco B Schaaf; Diede Houbaert; Odeta Meçe; Patrizia Agostinis
Journal:  Cell Death Differ       Date:  2019-01-28       Impact factor: 15.828

7.  ATG5-mediated autophagy suppresses NF-κB signaling to limit epithelial inflammatory response to kidney injury.

Authors:  Xuan Peng; Yating Wang; Huiyan Li; Jinjin Fan; Jiani Shen; Xueqing Yu; Yi Zhou; Haiping Mao
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469

Review 8.  Role of tumor and host autophagy in cancer metabolism.

Authors:  Laura Poillet-Perez; Eileen White
Journal:  Genes Dev       Date:  2019-06-01       Impact factor: 11.361

Review 9.  Tumor angiogenesis: causes, consequences, challenges and opportunities.

Authors:  Roberta Lugano; Mohanraj Ramachandran; Anna Dimberg
Journal:  Cell Mol Life Sci       Date:  2019-11-06       Impact factor: 9.261

10.  Exosome-transmitted linc00852 associated with receptor tyrosine kinase AXL dysregulates the proliferation and invasion of osteosarcoma.

Authors:  Qiming Li; Xuedi Wang; Nian Jiang; Xianbiao Xie; Ni Liu; JunFeng Liu; Jingnan Shen; Tingsheng Peng
Journal:  Cancer Med       Date:  2020-07-16       Impact factor: 4.452

View more
  14 in total

Review 1.  The role of lncRNA OIP5-AS1 in cancer development and progression.

Authors:  Cheng Zheng; Man Chu; Qiuli Chen; Cheng Chen; Zhi-Wei Wang; Xiao Chen
Journal:  Apoptosis       Date:  2022-03-22       Impact factor: 4.677

Review 2.  Autophagy and ncRNAs: Dangerous Liaisons in the Crosstalk between the Tumor and Its Microenvironment.

Authors:  Gracie Wee Ling Eng; Yilong Zheng; Dominic Wei Ting Yap; Andrea York Tiang Teo; Jit Kong Cheong
Journal:  Cancers (Basel)       Date:  2021-12-21       Impact factor: 6.639

Review 3.  New Insights Into the Regulatory Roles of Extracellular Vesicles in Tumor Angiogenesis and Their Clinical Implications.

Authors:  Maohua Huang; Yuhe Lei; Yinqin Zhong; Chiwing Chung; Mei Wang; Min Hu; Lijuan Deng
Journal:  Front Cell Dev Biol       Date:  2021-12-13

Review 4.  Extracellular Vesicles in Osteosarcoma: Antagonists or Therapeutic Agents?

Authors:  Viviana De Martino; Michela Rossi; Giulia Battafarano; Jessica Pepe; Salvatore Minisola; Andrea Del Fattore
Journal:  Int J Mol Sci       Date:  2021-11-22       Impact factor: 5.923

Review 5.  The emerging roles of exosomal long non-coding RNAs in bladder cancer.

Authors:  Qiang Liu
Journal:  J Cell Mol Med       Date:  2022-01-03       Impact factor: 5.310

Review 6.  The Utility of Exosomes in Diagnosis and Therapy of Diabetes Mellitus and Associated Complications.

Authors:  Yaoxiang Sun; Qing Tao; Xueqin Wu; Ling Zhang; Qi Liu; Lei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-10-26       Impact factor: 5.555

Review 7.  Mesenchymal Stem Cells and Extracellular Vesicles in Osteosarcoma Pathogenesis and Therapy.

Authors:  Virinder Kaur Sarhadi; Ravindra Daddali; Riitta Seppänen-Kaijansinkko
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

Review 8.  Review of the Role of Mesenchymal Stem Cells and Exosomes Derived from Mesenchymal Stem Cells in the Treatment of Orthopedic Disease.

Authors:  Sihang Ren; Chenchao Wang; Shu Guo
Journal:  Med Sci Monit       Date:  2022-04-28

Review 9.  Long non-coding RNA OIP5-AS1 (Cyrano): A context-specific regulator of normal and disease processes.

Authors:  Serena Wooten; Keriayn N Smith
Journal:  Clin Transl Med       Date:  2022-01

Review 10.  Noncoding RNAs of Extracellular Vesicles in Tumor Angiogenesis: From Biological Functions to Clinical Significance.

Authors:  Miao Hu; Juan Li; Chen-Guang Liu; Robby Miguel W J Goh; Fenggang Yu; Zhaowu Ma; Lingzhi Wang
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.